Hilary Glen
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 14
-
- Renal cell carcinoma treatment 19
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research 4
- Colorectal Cancer Treatments and Studies 3
- Hepatology top 10%
-
- Renal and related cancers 9
- Angiogenesis and VEGF in Cancer 3
-
- Economic and Financial Impacts of Cancer 4
-
- Cancer Mechanisms and Therapy 2
- Co-authors
- James LarkinCorina E. DutcusRobert J. MotzerM. Dror MichaelsonKaren WoodJakub ŻołnierekPablo MarotoBohuslav Melichar
- Journals
- Journal of Clinical Oncology (12 papers)The Lancet Oncology (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- United KingdomUnited StatesSpain
In The Last Decade
Hilary Glen
34 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 75
- Cancer Research 453
- Pulmonary and Respiratory Medicine 845
- Oncology 475
- Hepatology 99
- Molecular Biology 668
Countries citing papers authored by Hilary Glen
This map shows the geographic impact of Hilary Glen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hilary Glen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hilary Glen more than expected).
Fields of papers citing papers by Hilary Glen
This network shows the impact of papers produced by Hilary Glen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hilary Glen. The network helps show where Hilary Glen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hilary Glen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 35 | |
| 2 | 2022 | 17 | |
| 3 | 2022 | 1 | |
| 4 | 2021 | 5 | |
| 5 | 2020 | 10 | |
| 6 | 2020 | 13 | |
| 7 | 2019 | 20 | |
| 8 | 2018 | 8 | |
| 9 | 2018 | 3 | |
| 10 | 2018 | 12 | |
| 11 | 2016 | 11 | |
| 12 | Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trialbreakdown → | 2015 | 688 |
| 13 | 2015 | 10 | |
| 14 | 2015 | 10 | |
| 15 | 2012 | 150 | |
| 16 | 2011 | 75 | |
| 17 | 2008 | 5 | |
| 18 | 2006 | 10 | |
| 19 | 2005 | 20 | |
| 20 | 2003 | 9 |
About Hilary Glen
Hilary Glen is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Oncology, having authored 34 papers that have together received 1.3k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (19 papers), Cancer Genomics and Diagnostics (14 papers), Renal and related cancers (9 papers), Pancreatic and Hepatic Oncology Research (4 papers), Economic and Financial Impacts of Cancer (4 papers), Colorectal Cancer Treatments and Studies (3 papers), Angiogenesis and VEGF in Cancer (3 papers) and Cancer Mechanisms and Therapy (2 papers). The work is most often cited by research in Cancer Research (453 citations), Pulmonary and Respiratory Medicine (845 citations) and Oncology (475 citations). Hilary Glen has collaborated with scholars based in United Kingdom, United States and Spain. Frequent co-authors include James Larkin, Corina E. Dutcus, Robert J. Motzer, M. Dror Michaelson, Karen Wood, Jakub Żołnierek, Pablo Maroto, Bohuslav Melichar, Thomas E. Hutson and Jacek Jassem. Their work appears in journals such as Journal of Clinical Oncology, The Lancet Oncology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.